These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10335679)

  • 1. Prognostic and therapeutic significance of low levels of high-density lipoprotein cholesterol: current perspectives.
    Gotto AM
    Arch Intern Med; 1999 May; 159(10):1038-40. PubMed ID: 10335679
    [No Abstract]   [Full Text] [Related]  

  • 2. New perspectives on the management of low levels of high-density lipoprotein cholesterol.
    Harper CR; Jacobson TA
    Arch Intern Med; 1999 May; 159(10):1049-57. PubMed ID: 10335681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid disorders.
    Kole LA
    JAAPA; 2009 Nov; 22(11):54-5. PubMed ID: 19999177
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on the management of dyslipidemia.
    Irons BK; Snella KA; McCall K; MacLaughlin EJ; Villarreal M
    Am J Health Syst Pharm; 2002 Sep; 59(17):1615-25. PubMed ID: 12224342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein analysis.
    Colyar MR
    Adv Nurse Pract; 2002 May; 10(5):30-2. PubMed ID: 12420528
    [No Abstract]   [Full Text] [Related]  

  • 6. Aggressive medical therapy for the prevention and treatment of coronary artery disease.
    Malloy MJ; Kane JP
    Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050
    [No Abstract]   [Full Text] [Related]  

  • 7. [Overviews of fibrate].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
    [No Abstract]   [Full Text] [Related]  

  • 8. Increasing high-density lipoprotein cholesterol: an update on fenofibrate.
    Després JP
    Am J Cardiol; 2001 Dec; 88(12A):30N-36N. PubMed ID: 11788128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia and coronary artery disease.
    Genest JG
    Can J Cardiol; 2000 Jan; 16 Suppl A():3A-4A. PubMed ID: 10653923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidemia and coronary heart disease: management issues from Indian perspective.
    Gambhir DS; Gambhir JK; Sudha R
    Indian Heart J; 2000; 52(5):515-6, 617. PubMed ID: 11256772
    [No Abstract]   [Full Text] [Related]  

  • 11. Taking aim at HDL-C. Raising levels to reduce cardiovascular risk.
    McGovern ME
    Postgrad Med; 2005 Apr; 117(4):29-30, 33-5, 39 passim. PubMed ID: 15842130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDL cholesterol studies--more of the same?
    Després JP
    Nat Rev Cardiol; 2013 Feb; 10(2):70-2. PubMed ID: 23319099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond low-density lipoprotein cholesterol. A perspective on low high-density lipoprotein disorders and Lp(a) lipoprotein excess.
    Rosenson RS
    Arch Intern Med; 1996 Jun; 156(12):1278-84. PubMed ID: 8651835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of setting standards and guidelines for management of patients with hyperlipidemia].
    Kotake H; Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():492-9. PubMed ID: 11347119
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)?
    Sherrod JP; Krist A
    J Fam Pract; 2001 Nov; 50(11):928. PubMed ID: 11711006
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial lipoprotein disorders and premature coronary artery disease.
    Schaefer EJ; Genest JJ; Ordovas JM; Salem DN; Wilson PW
    Atherosclerosis; 1994 Aug; 108 Suppl():S41-54. PubMed ID: 7802728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High cholesterol levels are discriminated by new therapeutic recommendations].
    Olsson AG
    Lakartidningen; 2000 Apr; 97(16):1995-6. PubMed ID: 10826361
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetes.
    Wägner AM; Ordóñez-Llanos J; Jorba O; Pérez A
    Metabolism; 2004 Nov; 53(11):1516. PubMed ID: 15558848
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of hyperlipidemia.
    Gotto AM
    Am J Cardiol; 1986 May; 57(14):11G-16G. PubMed ID: 3521247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.